Stay updated on Pembrolizumab in Lymphopenic Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in Lymphopenic Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in Lymphopenic Breast Cancer Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    Recruitment status now indicates no participants are being sought, and new navigation/help sections were added (How to Read a Study Record, Common Questions, How to Join a Study). A labeling change for Intervention/Treatment and a Revision tag were also updated.
    Difference
    0.4%
    Check dated 2026-06-12T16:12:46.000Z thumbnail image
  2. Check
    14 days ago
    Change Detected
    Summary
    The page now shows a newer revision label (v3.5.5) replacing the previous v3.5.4, indicating an updated build of the page.
    Difference
    0.1%
    Check dated 2026-06-05T11:45:53.000Z thumbnail image
  3. Check
    21 days ago
    No Change Detected
  4. Check
    28 days ago
    No Change Detected
  5. Check
    35 days ago
    Change Detected
    Summary
    The page revision was updated from v3.5.3 to v3.5.4, indicating a minor update to the page metadata. This reflects a small version change without altering the visible content.
    Difference
    0.1%
    Check dated 2026-05-15T03:23:32.000Z thumbnail image
  6. Check
    50 days ago
    Change Detected
    Summary
    The page revision tag was updated from v3.5.2 to v3.5.3, signaling a backend update to the site. There is no indication of changes to the study details or how the page presents information.
    Difference
    0.1%
    Check dated 2026-04-30T17:52:52.000Z thumbnail image
  7. Check
    64 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-16T10:51:30.000Z thumbnail image
  8. Check
    93 days ago
    Change Detected
    Summary
    Revision: v3.5.0 added and v3.4.3 removed.
    Difference
    0.1%
    Check dated 2026-03-18T18:08:21.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in Lymphopenic Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Lymphopenic Breast Cancer Clinical Trial page.